This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Service. This report contains market size and forecasts of PARP Inhibitor Biomarkers Service in global, including the following market information:
Global PARP Inhibitor Biomarkers Service Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global PARP Inhibitor Biomarkers Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
BRCA 1 & 2 Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of PARP Inhibitor Biomarkers Service include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc. and BPS Bioscience, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the PARP Inhibitor Biomarkers Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PARP Inhibitor Biomarkers Service Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global PARP Inhibitor Biomarkers Service Market Segment Percentages, by Type, 2022 (%)
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others
Global PARP Inhibitor Biomarkers Service Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global PARP Inhibitor Biomarkers Service Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global PARP Inhibitor Biomarkers Service Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global PARP Inhibitor Biomarkers Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PARP Inhibitor Biomarkers Service revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies PARP Inhibitor Biomarkers Service revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of PARP Inhibitor Biomarkers Service, market overview.
Chapter 2: Global PARP Inhibitor Biomarkers Service market size in revenue.
Chapter 3: Detailed analysis of PARP Inhibitor Biomarkers Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PARP Inhibitor Biomarkers Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 PARP Inhibitor Biomarkers Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PARP Inhibitor Biomarkers Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PARP Inhibitor Biomarkers Service Overall Market Size
2.1 Global PARP Inhibitor Biomarkers Service Market Size: 2022 VS 2032
2.2 Global PARP Inhibitor Biomarkers Service Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PARP Inhibitor Biomarkers Service Players in Global Market
3.2 Top Global PARP Inhibitor Biomarkers Service Companies Ranked by Revenue
3.3 Global PARP Inhibitor Biomarkers Service Revenue by Companies
3.4 Top 3 and Top 5 PARP Inhibitor Biomarkers Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies PARP Inhibitor Biomarkers Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 PARP Inhibitor Biomarkers Service Players in Global Market
3.6.1 List of Global Tier 1 PARP Inhibitor Biomarkers Service Companies
3.6.2 List of Global Tier 2 and Tier 3 PARP Inhibitor Biomarkers Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global PARP Inhibitor Biomarkers Service Market Size Markets, 2022 & 2032
4.1.2 BRCA 1 & 2 Testing
4.1.3 HRD Testing
4.1.4 HRR Testing
4.1.5 Others
4.2 By Type - Global PARP Inhibitor Biomarkers Service Revenue & Forecasts
4.2.1 By Type - Global PARP Inhibitor Biomarkers Service Revenue, 2018-2023
4.2.2 By Type - Global PARP Inhibitor Biomarkers Service Revenue, 2024-2032
4.2.3 By Type - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PARP Inhibitor Biomarkers Service Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global PARP Inhibitor Biomarkers Service Revenue & Forecasts
5.2.1 By Application - Global PARP Inhibitor Biomarkers Service Revenue, 2018-2023
5.2.2 By Application - Global PARP Inhibitor Biomarkers Service Revenue, 2024-2032
5.2.3 By Application - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global PARP Inhibitor Biomarkers Service Market Size, 2022 & 2032
6.2 By Region - Global PARP Inhibitor Biomarkers Service Revenue & Forecasts
6.2.1 By Region - Global PARP Inhibitor Biomarkers Service Revenue, 2018-2023
6.2.2 By Region - Global PARP Inhibitor Biomarkers Service Revenue, 2024-2032
6.2.3 By Region - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America PARP Inhibitor Biomarkers Service Revenue, 2018-2032
6.3.2 US PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.3.3 Canada PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.3.4 Mexico PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe PARP Inhibitor Biomarkers Service Revenue, 2018-2032
6.4.2 Germany PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4.3 France PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4.4 U.K. PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4.5 Italy PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4.6 Russia PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4.7 Nordic Countries PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.4.8 Benelux PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia PARP Inhibitor Biomarkers Service Revenue, 2018-2032
6.5.2 China PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.5.3 Japan PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.5.4 South Korea PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.5.5 Southeast Asia PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.5.6 India PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America PARP Inhibitor Biomarkers Service Revenue, 2018-2032
6.6.2 Brazil PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.6.3 Argentina PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PARP Inhibitor Biomarkers Service Revenue, 2018-2032
6.7.2 Turkey PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.7.3 Israel PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.7.4 Saudi Arabia PARP Inhibitor Biomarkers Service Market Size, 2018-2032
6.7.5 UAE PARP Inhibitor Biomarkers Service Market Size, 2018-2032
7 PARP Inhibitor Biomarkers Service Companies Profiles
7.1 Myriad Genetics, Inc.
7.1.1 Myriad Genetics, Inc. Company Summary
7.1.2 Myriad Genetics, Inc. Business Overview
7.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Major Product Offerings
7.1.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Revenue in Global Market (2018-2023)
7.1.5 Myriad Genetics, Inc. Key News & Latest Developments
7.2 Hoffmann-La Roche AG
7.2.1 Hoffmann-La Roche AG Company Summary
7.2.2 Hoffmann-La Roche AG Business Overview
7.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Major Product Offerings
7.2.4 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Revenue in Global Market (2018-2023)
7.2.5 Hoffmann-La Roche AG Key News & Latest Developments
7.3 Invitae Corporation
7.3.1 Invitae Corporation Company Summary
7.3.2 Invitae Corporation Business Overview
7.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Major Product Offerings
7.3.4 Invitae Corporation PARP Inhibitor Biomarkers Service Revenue in Global Market (2018-2023)
7.3.5 Invitae Corporation Key News & Latest Developments
7.4 NeoGenomics Laboratories, Inc.
7.4.1 NeoGenomics Laboratories, Inc. Company Summary
7.4.2 NeoGenomics Laboratories, Inc. Business Overview
7.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Major Product Offerings
7.4.4 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Revenue in Global Market (2018-2023)
7.4.5 NeoGenomics Laboratories, Inc. Key News & Latest Developments
7.5 BPS Bioscience, Inc.
7.5.1 BPS Bioscience, Inc. Company Summary
7.5.2 BPS Bioscience, Inc. Business Overview
7.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Major Product Offerings
7.5.4 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Revenue in Global Market (2018-2023)
7.5.5 BPS Bioscience, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. PARP Inhibitor Biomarkers Service Market Opportunities & Trends in Global Market
Table 2. PARP Inhibitor Biomarkers Service Market Drivers in Global Market
Table 3. PARP Inhibitor Biomarkers Service Market Restraints in Global Market
Table 4. Key Players of PARP Inhibitor Biomarkers Service in Global Market
Table 5. Top PARP Inhibitor Biomarkers Service Players in Global Market, Ranking by Revenue (2022)
Table 6. Global PARP Inhibitor Biomarkers Service Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global PARP Inhibitor Biomarkers Service Revenue Share by Companies, 2018-2023
Table 8. Global Companies PARP Inhibitor Biomarkers Service Product Type
Table 9. List of Global Tier 1 PARP Inhibitor Biomarkers Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PARP Inhibitor Biomarkers Service Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - PARP Inhibitor Biomarkers Service Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - PARP Inhibitor Biomarkers Service Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - PARP Inhibitor Biomarkers Service Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - PARP Inhibitor Biomarkers Service Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global PARP Inhibitor Biomarkers Service Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global PARP Inhibitor Biomarkers Service Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2024-2032
Table 30. Myriad Genetics, Inc. Company Summary
Table 31. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Product Offerings
Table 32. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Revenue (US$, Mn) & (2018-2023)
Table 33. Myriad Genetics, Inc. Key News & Latest Developments
Table 34. Hoffmann-La Roche AG Company Summary
Table 35. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Product Offerings
Table 36. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Revenue (US$, Mn) & (2018-2023)
Table 37. Hoffmann-La Roche AG Key News & Latest Developments
Table 38. Invitae Corporation Company Summary
Table 39. Invitae Corporation PARP Inhibitor Biomarkers Service Product Offerings
Table 40. Invitae Corporation PARP Inhibitor Biomarkers Service Revenue (US$, Mn) & (2018-2023)
Table 41. Invitae Corporation Key News & Latest Developments
Table 42. NeoGenomics Laboratories, Inc. Company Summary
Table 43. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Product Offerings
Table 44. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Revenue (US$, Mn) & (2018-2023)
Table 45. NeoGenomics Laboratories, Inc. Key News & Latest Developments
Table 46. BPS Bioscience, Inc. Company Summary
Table 47. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Product Offerings
Table 48. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Revenue (US$, Mn) & (2018-2023)
Table 49. BPS Bioscience, Inc. Key News & Latest Developments
List of Figures
Figure 1. PARP Inhibitor Biomarkers Service Segment by Type in 2022
Figure 2. PARP Inhibitor Biomarkers Service Segment by Application in 2022
Figure 3. Global PARP Inhibitor Biomarkers Service Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global PARP Inhibitor Biomarkers Service Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global PARP Inhibitor Biomarkers Service Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by PARP Inhibitor Biomarkers Service Revenue in 2022
Figure 8. By Type - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 9. By Application - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 10. By Type - Global PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 12. By Application - Global PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 14. By Region - Global PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 15. By Country - North America PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 16. US PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 17. Canada PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 20. Germany PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 21. France PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 23. Italy PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 24. Russia PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 28. China PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 29. Japan PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 32. India PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 34. Brazil PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa PARP Inhibitor Biomarkers Service Revenue Market Share, 2018-2032
Figure 37. Turkey PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 38. Israel PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 40. UAE PARP Inhibitor Biomarkers Service Revenue, (US$, Mn), 2018-2032
Figure 41. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Invitae Corporation PARP Inhibitor Biomarkers Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
